Skip to main content
Top
Published in: Gut Pathogens 1/2010

Open Access 01-12-2010 | Research

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

Authors: Ian M Carroll, Young-Hyo Chang, Jiwon Park, R Balfour Sartor, Yehuda Ringel

Published in: Gut Pathogens | Issue 1/2010

Login to get access

Abstract

Background

Recent studies have suggested a role for an altered intestinal microbiota in the pathophysiology of irritable bowel syndrome (IBS). However, no consensus has been reached regarding the association between specific enteric bacterial groups and IBS. The aim of this study was to investigate the fecal and mucosal-associated microbiota using two independent techniques in intestinal samples from diarrhea-predominant IBS (D-IBS) and healthy controls.

Methods

Fecal and colonic mucosal biopsy samples were obtained from 10 D-IBS patients and 10 healthy controls. Colonic tissue was collected during a un-sedated un-prepped flexible sigmoidoscopy. Fecal and tissue samples were processed immediately upon collection for culture under aerobic and anaerobic conditions or frozen for further molecular analysis. DNA was extracted from all frozen samples and used to enumerate specific bacterial groups using quantitative real-time PCR (qPCR).

Results

Culture analysis of intestinal samples demonstrated a significant reduction in the concentration of aerobic bacteria in fecal samples from D-IBS patients when compared to healthy controls (1.4 × 107 vs. 8.4 × 108 CFUs/g feces, P = 0.002). qPCR analysis demonstrated a significant 3.6 fold increase (P = 0.02) in concentrations of fecal Lactobacillus species between D-IBS patients and healthy controls.

Conclusions

Our culture and molecular data indicate that quantitative differences exist in specific bacterial groups in the microbiota between D-IBS and healthy subjects.
Appendix
Available only for authorised users
Literature
1.
go back to reference Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology. 2006, 130 (5): 1480-1491. 10.1053/j.gastro.2005.11.061.CrossRefPubMed Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology. 2006, 130 (5): 1480-1491. 10.1053/j.gastro.2005.11.061.CrossRefPubMed
2.
go back to reference Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006, 130 (5): 1377-1390. 10.1053/j.gastro.2006.03.008.CrossRefPubMed Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006, 130 (5): 1377-1390. 10.1053/j.gastro.2006.03.008.CrossRefPubMed
3.
go back to reference Ringel Y, Carroll IM: Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am. 2009, 19 (1): 141-150. 10.1016/j.giec.2008.12.004. viiCrossRefPubMed Ringel Y, Carroll IM: Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am. 2009, 19 (1): 141-150. 10.1016/j.giec.2008.12.004. viiCrossRefPubMed
4.
go back to reference Ringel Y, Sperber AD, Drossman DA: Irritable bowel syndrome. Annu Rev Med. 2001, 52: 319-338. 10.1146/annurev.med.52.1.319.CrossRefPubMed Ringel Y, Sperber AD, Drossman DA: Irritable bowel syndrome. Annu Rev Med. 2001, 52: 319-338. 10.1146/annurev.med.52.1.319.CrossRefPubMed
5.
go back to reference Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC: Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007, 19 (1 Suppl): 62-88. 10.1111/j.1365-2982.2006.00875.x.CrossRefPubMed Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC: Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007, 19 (1 Suppl): 62-88. 10.1111/j.1365-2982.2006.00875.x.CrossRefPubMed
6.
go back to reference Scanu AM, Bull TJ, Cannas S, Sanderson JD, Sechi LA, Dettori G, Zanetti S, Hermon-Taylor J: Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities. J Clin Microbiol. 2007, 45 (12): 3883-3890. 10.1128/JCM.01371-07.PubMedCentralCrossRefPubMed Scanu AM, Bull TJ, Cannas S, Sanderson JD, Sechi LA, Dettori G, Zanetti S, Hermon-Taylor J: Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities. J Clin Microbiol. 2007, 45 (12): 3883-3890. 10.1128/JCM.01371-07.PubMedCentralCrossRefPubMed
7.
8.
go back to reference Spiller RC: Is IBS caused by infectious diarrhea? Nat Clin Pract Gastroenterol Hepatol. 2007, 4 (12): 642-643.CrossRefPubMed Spiller RC: Is IBS caused by infectious diarrhea? Nat Clin Pract Gastroenterol Hepatol. 2007, 4 (12): 642-643.CrossRefPubMed
9.
go back to reference Pimentel M, Chow EJ, Lin HC: Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003, 98 (2): 412-419.PubMed Pimentel M, Chow EJ, Lin HC: Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003, 98 (2): 412-419.PubMed
10.
go back to reference Pimentel M: Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009, 18 (3): 349-358. 10.1517/13543780902780175.CrossRefPubMed Pimentel M: Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009, 18 (3): 349-358. 10.1517/13543780902780175.CrossRefPubMed
11.
go back to reference Pimentel M, Chow EJ, Lin HC: Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000, 95 (12): 3503-3506. 10.1111/j.1572-0241.2000.03368.x.CrossRefPubMed Pimentel M, Chow EJ, Lin HC: Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000, 95 (12): 3503-3506. 10.1111/j.1572-0241.2000.03368.x.CrossRefPubMed
12.
go back to reference Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G: The fecal microbial population in the irritable bowel syndrome. Microbiologica. 1982, 5 (3): 185-194.PubMed Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G: The fecal microbial population in the irritable bowel syndrome. Microbiologica. 1982, 5 (3): 185-194.PubMed
13.
go back to reference Si JM, Yu YC, Fan YJ, Chen SJ: Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol. 2004, 10 (12): 1802-1805.PubMedCentralCrossRefPubMed Si JM, Yu YC, Fan YJ, Chen SJ: Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol. 2004, 10 (12): 1802-1805.PubMedCentralCrossRefPubMed
14.
go back to reference Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR: A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome. Dig Dis Sci. 2010, 55 (2): 392-397. 10.1007/s10620-009-0934-x.CrossRefPubMed Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR: A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome. Dig Dis Sci. 2010, 55 (2): 392-397. 10.1007/s10620-009-0934-x.CrossRefPubMed
15.
go back to reference Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A: The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007, 133 (1): 24-33. 10.1053/j.gastro.2007.04.005.CrossRefPubMed Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A: The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007, 133 (1): 24-33. 10.1053/j.gastro.2007.04.005.CrossRefPubMed
16.
go back to reference Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A: Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005, 100 (2): 373-382. 10.1111/j.1572-0241.2005.40312.x.CrossRefPubMed Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A: Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005, 100 (2): 373-382. 10.1111/j.1572-0241.2005.40312.x.CrossRefPubMed
17.
go back to reference Matto J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M: Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol. 2005, 43 (2): 213-222. 10.1016/j.femsim.2004.08.009.CrossRefPubMed Matto J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M: Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol. 2005, 43 (2): 213-222. 10.1016/j.femsim.2004.08.009.CrossRefPubMed
18.
go back to reference Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H: Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005, 43 (7): 3380-3389. 10.1128/JCM.43.7.3380-3389.2005.PubMedCentralCrossRefPubMed Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H: Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005, 43 (7): 3380-3389. 10.1128/JCM.43.7.3380-3389.2005.PubMedCentralCrossRefPubMed
19.
go back to reference Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S: Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010, 22 (55): 512-519.PubMed Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S: Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010, 22 (55): 512-519.PubMed
20.
go back to reference Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Makivuokko H, Kajander K, Palva A: Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009, 9: 95-10.1186/1471-230X-9-95.PubMedCentralCrossRefPubMed Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Makivuokko H, Kajander K, Palva A: Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009, 9: 95-10.1186/1471-230X-9-95.PubMedCentralCrossRefPubMed
21.
go back to reference Lyra A, Rinttila T, Nikkila J, Krogius-Kurikka L, Kajander K, Malinen E, Matto J, Makela L, Palva A: Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol. 2009, 15 (47): 5936-5945. 10.3748/wjg.15.5936.PubMedCentralCrossRefPubMed Lyra A, Rinttila T, Nikkila J, Krogius-Kurikka L, Kajander K, Malinen E, Matto J, Makela L, Palva A: Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol. 2009, 15 (47): 5936-5945. 10.3748/wjg.15.5936.PubMedCentralCrossRefPubMed
22.
go back to reference Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM: Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002, 68 (7): 3401-3407. 10.1128/AEM.68.7.3401-3407.2002.PubMedCentralCrossRefPubMed Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM: Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002, 68 (7): 3401-3407. 10.1128/AEM.68.7.3401-3407.2002.PubMedCentralCrossRefPubMed
23.
go back to reference Caenepeel P, Janssens J, Vantrappen G, Eyssen H, Coremans G: Interdigestive myoelectric complex in germ-free rats. Dig Dis Sci. 1989, 34 (8): 1180-1184. 10.1007/BF01537265.CrossRefPubMed Caenepeel P, Janssens J, Vantrappen G, Eyssen H, Coremans G: Interdigestive myoelectric complex in germ-free rats. Dig Dis Sci. 1989, 34 (8): 1180-1184. 10.1007/BF01537265.CrossRefPubMed
24.
go back to reference Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T: Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol. 2001, 280 (3): G368-380.PubMed Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T: Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol. 2001, 280 (3): G368-380.PubMed
25.
go back to reference Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM: Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009, 15 (23): 2887-2892. 10.3748/wjg.15.2887.PubMedCentralCrossRefPubMed Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM: Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009, 15 (23): 2887-2892. 10.3748/wjg.15.2887.PubMedCentralCrossRefPubMed
26.
go back to reference Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R: Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004, 70 (12): 7220-7228. 10.1128/AEM.70.12.7220-7228.2004.PubMedCentralCrossRefPubMed Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R: Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004, 70 (12): 7220-7228. 10.1128/AEM.70.12.7220-7228.2004.PubMedCentralCrossRefPubMed
27.
go back to reference Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004, 97 (6): 1166-1177. 10.1111/j.1365-2672.2004.02409.x.CrossRefPubMed Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004, 97 (6): 1166-1177. 10.1111/j.1365-2672.2004.02409.x.CrossRefPubMed
28.
go back to reference Malinen E, Kassinen A, Rinttila T, Palva A: Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology. 2003, 149 (Pt 1): 269-277. 10.1099/mic.0.25975-0.CrossRefPubMed Malinen E, Kassinen A, Rinttila T, Palva A: Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology. 2003, 149 (Pt 1): 269-277. 10.1099/mic.0.25975-0.CrossRefPubMed
29.
go back to reference Bartosch S, Fite A, Macfarlane GT, McMurdo ME: Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol. 2004, 70 (6): 3575-3581. 10.1128/AEM.70.6.3575-3581.2004.PubMedCentralCrossRefPubMed Bartosch S, Fite A, Macfarlane GT, McMurdo ME: Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol. 2004, 70 (6): 3575-3581. 10.1128/AEM.70.6.3575-3581.2004.PubMedCentralCrossRefPubMed
30.
go back to reference Maeda H, Fujimoto C, Haruki Y, Maeda T, Kokeguchi S, Petelin M, Arai H, Tanimoto I, Nishimura F, Takashiba S: Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunol Med Microbiol. 2003, 39 (1): 81-86. 10.1016/S0928-8244(03)00224-4.CrossRefPubMed Maeda H, Fujimoto C, Haruki Y, Maeda T, Kokeguchi S, Petelin M, Arai H, Tanimoto I, Nishimura F, Takashiba S: Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunol Med Microbiol. 2003, 39 (1): 81-86. 10.1016/S0928-8244(03)00224-4.CrossRefPubMed
Metadata
Title
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Authors
Ian M Carroll
Young-Hyo Chang
Jiwon Park
R Balfour Sartor
Yehuda Ringel
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2010
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/1757-4749-2-19

Other articles of this Issue 1/2010

Gut Pathogens 1/2010 Go to the issue